inogatran has been researched along with Arteriosclerosis, Coronary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frebelius, S; Grip, L; Linder, R; Swedenborg, J | 1 |
| Grip, L; Linder, R; Oldgren, J; Siegbahn, A; Thygesen, K; Wallentin, L | 1 |
1 trial(s) available for inogatran and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Topics: Adult; Aged; Biomarkers; Blood Coagulation; Coronary Artery Disease; Glycine; Heparin; Humans; Middle Aged; Myocardial Ischemia; Piperidines; Predictive Value of Tests; Risk Factors; Thrombin; Thrombophilia; Treatment Failure; Treatment Outcome; Troponin T | 2004 |
1 other study(ies) available for inogatran and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
The influence of direct and antithrombin-dependent thrombin inhibitors on the procoagulant and anticoagulant effects of thrombin.
Topics: Amino Acid Chloromethyl Ketones; Anticoagulants; Azetidines; Benzylamines; Clinical Trials as Topic; Coagulants; Coronary Artery Disease; Fibrinopeptide A; Glycine; Hirudins; Humans; Peptide Fragments; Piperidines; Protein C; Thrombin | 2003 |